Evidence map›Paper›PMID 34489414›Full record

ArticleNature communications2021

Genetically encoded cell-death indicators (GEDI) to detect an early irreversible commitment to neurodegeneration.

Jeremy W Linsley, Kevan Shah, Nicholas Castello, Michelle Chan, Dominik Haddad, Zak Doric, Shijie Wang, Wiktoria Leks, Jay Mancini, Viral Oza and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular Visualization of Neuronal TDP43 PathologybioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Zebrafish as a model organism for neurodegenerative disease.Frontiers in molecular neuroscience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jeremy W LinsleyGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.ORCID 0000-0001-6464-8728
Kevan ShahGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.ORCID 0000-0002-6284-2030
Nicholas CastelloGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.
Michelle ChanGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.
Dominik HaddadGladstone Institute of Neurologic Disease, San Francisco, CA, USA.
Zak DoricGladstone Institute of Neurologic Disease, San Francisco, CA, USA.ORCID 0000-0003-2608-4196
Shijie WangGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.
Wiktoria LeksGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.
Jay ManciniGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.
Viral OzaGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.
Ashkan JavaherianGladstone Center for Systems and Therapeutics, San Francisco, CA, USA.
Ken NakamuraGladstone Institute of Neurologic Disease, San Francisco, CA, USA.ORCID 0000-0002-9192-182X
David KokelDepartment of Physiology, University of California, San Francisco, CA, USA.
Steven FinkbeinerGladstone Center for Systems and Therapeutics, San Francisco, CA, USA. sfinkbeiner@gladstone.ucsf.edu.ORCID 0000-0002-3480-394X
Gladstone Institutes · USUniversity of California, San Francisco · US

Funding

The Psychiatric Cell Map Initiative: Connecting Genomics, Subcellular Networks, and Higher Order PhenotypesU01MH115747 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAMPMANN, MARTIN, KROGAN, NEVAN J · 2018 to 2022
$19.6M
The proteasome in aging and neurodegenerative diseaseP01AG054407 · NIA · NORTHWESTERN UNIVERSITY · PI MORIMOTO, RICHARD I · 2018 to 2022
$14.0M
Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells-SupplementU54NS091046 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI FINKBEINER, STEVEN M, FRAENKEL, ERNEST · 2014 to 2020
$11.7M
Rare Variant Whole Genome Analysis and iPSC Validation of Putative Genetic Modifiers of Huntington DiseaseR37NS101996 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2017 to 2023
$4.4M
Dysfunction of the Autophagy-Lysosomal Pathway as a Common Mechanism of NeurodegenerationRF1AG058476 · NIA · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2017 to 2018
$4.1M
Tauopathy in AD and FTD - Molecular Determinants of Phenotypic DiversityRF1AG056151 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CARLSON, GEORGE A., DUFF, KAREN · 2017 to 2017
$4.1M
Understand and probing disrupted glucose metabolism in Alzheimer's diseaseRF1AG064170 · NIA · J. DAVID GLADSTONE INSTITUTES · PI CHAUMEIL, MYRIAM MARIANNE, NAKAMURA, KEN · 2019 to 2019
$3.6M
Role of central and peripheral immune crosstalk in FTD-Grn neurodegenerationRF1NS128800 · NINDS · UNIVERSITY OF FLORIDA · PI FINKBEINER, STEVEN M, TANSEY, MARIA DE LOURDES GAMEZ · 2022 to 2022
$2.4M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR018928 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI MAHLEY, ROBERT W. · 2003 to 2003
$2.1M
Discovery of Novel Drugs that Increase Tau Clearance to Treat Alzheimer's DiseaseRF1AG058447 · NIA · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2018 to 2018
$1.8M
Image Tools for Computational Cellular Barcoding and Automated AnnotationR01LM013617 · NLM · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2022 to 2025
$1.6M
NCRR NIH HHS C06 RR018928NIA NIH HHS P01 AG054407NIA NIH HHS RF1 AG056151NIA NIH HHS RF1 AG058447NIA NIH HHS RF1 AG058476NIA NIH HHS RF1 AG064170NIMH NIH HHS U01 MH115747NINDS NIH HHS R37 NS101996NINDS NIH HHS RF1 NS128800NINDS NIH HHS U54 NS091046NLM NIH HHS R01 LM013617
6 · The paper itself

Abstract

Cell death is a critical process that occurs normally in health and disease. However, its study is limited due to available technologies that only detect very late stages in the process or specific death mechanisms. Here, we report the development of a family of fluorescent biosensors called genetically encoded death indicators (GEDIs). GEDIs specifically detect an intracellular Ca

Indexed as

Biosensing TechniquesGene Expression Regulation, Developmentalalpha-SynucleinAnimalsCalciumCell DeathCerebral CortexDisease Models, AnimalDNA-Binding ProteinsEmbryo, NonmammalianFluorescent DyesGenes, ReporterGlutamic AcidGreen Fluorescent ProteinsHumansLarvaalpha-SynucleinCalciumDNA-Binding Proteinsenhanced green fluorescent proteinFluorescent DyesGlutamic AcidGreen Fluorescent ProteinsSOD1 protein, humanSuperoxide Dismutase-1TARDBP protein, human

Identifiers

PMID34489414
PMCPMC8421388
OpenAlexW3196439039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.